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Marginated and bone marrow reserve granulocytes were obtained from young healthy volunteers after
subcutaneous administration of aqueous epinephrine (0.4 ml/m2) or intravenous administration of
hydrocortisone sodium succinate (250 mg), respectively. These leukocytes were compared with circulating
granulocytes for the ability to adhere to surfaces, migrate in a random fashion, respond to chemoattractants,
interact with autologous serum opsonins, and phagocytize and kill five common bacterial pathogens. As
contrasted with circulating neutrophils, marginated cells had enhanced phagocytic and killing capacity for
some pathogens, whereas adherence, random migration, chemotaxis, and chexniluminescence for the two cell
populations were equivalent. Bone marrow reserve cells demonstrated increased activity for three functional
mechanisms; chemotaxis for these cells averaged 21% higher than that for circulating cells, and phagocytosis
was 32% higher, with 6 to 17% greater killing of the five bacterial species studied. All of these differences were
statistically significant (P < 0.05). Random migration and interaction with serum opsonins were unchanged in
bone marrow granulocytes. These enhanced functional properties of neutrophils which are outside of the
circulating pool may represent important host defense mnechanisms during episodes of bacterial infection.
It has long been recognized in the clinical setting that
bacterial infections are accompanied by a peripheral blood
leukocytosis consisting predominately of granulocytes. This
increase in the absolute granulocyte count has often been
used as an indicator of bacterial as opposed to viral infection
in febrile patients (11, 18). These additional leukocytes
represent the mobilization of marginated cells and, to some
extent, bone marrow reserves, and it is speculated that this
mobilization reflects a host response to microbial invasion
which results in a more efficient elimination of pathogens (6).
The functional capacity of granulocyte reserves has been
evaluated indirectly by examining cells from infected neo-
nates (1, 16), children (8), and adults (3, 7, 10). Researchers
have observed some differences from normal circulating
cells and concluded these were evidence of impaired func-
tion (3, 16).
The present study was designed to comprehensively eval-
uate functional aspects of marginated and bone marrow
reserve granulocytes to delineate the potential contribution
of these responses to host defense against bacterial patho-
gens. Assays included quantitation of marginated cells,
adherence, random motility, response to chemoattractants,
interaction with serum opsonins, phagocytosis, and killing of
common bacterial pathogens.
MATERIALS AND METHODS
Subjects. Leukocytes were obtained from 10 normal
healthy adults, who received aqueous epinephrine or
hydrocortisone on 5 to 12 occasions during the 12-month
experiment. Informed consent was obtained, and the study
was approved by the Human Research Advisory Committee
of the University of Arkansas for Medical Sciences.
Demargination of granulocytes. On each study day, periph-
eral venous blood was first obtained by venipuncture, each
* Corresponding author.
volunteer was then given 0.4 ml of aqueous epinephrine
(1:1,000) per m2 of body surface area by subcutaneous
injection, and an additional sample of venous blood was
obtained 18 min after the injection. This optimal timing for
obtaining demarginated-leukocyte samples was determined
in earlier experiments in which blood was obtained every 3
min after epinephrine administration.
Circulating granulocytes (before epinephrine treatment)
and combined circulating and marginated granulocytes (after
epinephrine treatment) were isolated by a dual Ficoll-
Hypaque gradient separation technique. The double-layer
gradient was prepared by placing 2 ml of Mono-Poly Resolv-
ing Medium (specific gravity, 1.114; Flow Laboratories,
Inc.) in a 16-by-100-mm plastic centrifuge tube and carefully
layering 2 ml of Histopaque (specific gravity, 1.077; Sigma
Chemical Co.) over the first layer. Blood (4 ml) was gently
layered on top of the gradients and centrifuged at 250 x g for
30 min in a swinging-bucket rotor at 20°C. The top fraction
was discarded, and the lower fraction was collected and
washed once with Hanks balanced salt solution by centrifu-
gation at 400 x g for 10 min. To remove contaminating
erythrocytes, the cell pellet was suspended in 0.84% ammo-
nium chloride and incubated for 5 min in a 37°C water bath.
The granulocytes were washed three more times before they
were adjusted to the desired concentration. Such processing
did not alter the viability of polymorphonuclear leukocytes
(PMNs) from the circulating or marginated pool, as judged
by trypan blue dye exclusion.
Bone marrow reserve granulocytes. On other study days,
the same volunteers were given 250 mg of hydrocortisone
sodium succinate by rapid intravenous infusion, and periph-
eral blood was obtained 4 h later. Processing of granulocytes
was done as described above.
Adherence. Adherence was measured with nylon fiber
columns as previously described (9). Briefly, 50 mg of nylon
fiber was carefully packed into a Pasteur pipette to a length
of 15 mm. Blood (1 ml) was dispensed into the column and
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TABLE 1. Characteristics of circulating and marginated granulocytesa
Peak chemiluminescence response (cpm) with:
Granulocyteb Adherence (%) Random migrationc ChemotaxisP
Zymosan S. pneumonia S. aureus
Pre 58 ± 4 473 + 58 1,262 ± 139 364,228 ± 50,507 53,945 ± 7,195 92,018 ± 4,041
Post 60 ± 5 514 ± 39 1,347 ± 80 394,801 ± 58,711 53,124 ± 7,314 95,687 ± 7,024
a Values are expressed as the mean of 12 samples ± the standard error of the mean. P values (Pre and Post) were not significant.
b Pre, Circulating granulocytes isolated before epinephrine treatment; Post, marginated granulocytes isolated after epinephrine treatment.
C Number of migrated cells in a single plane.
allowed to filter through the nylon fiber by gravity. The
precolumn granulocyte count and differential were com-
pared with the effluent blood count to ascertain the percent-
age of granulocytes adhering to the column. The percentage
of adherent granulocytes was calculated as follows: % ad-
herence = 100 - {[(granulocytes per milliliter in effluent
sample)/(granulocytes per milliliter in original sample)] x
100}.
Random migration and chemotaxis. Granulocyte random
migration and chemotaxis were assessed by a modification of
the chemotaxis-under-agarose technique (4). A series of
three wells, 4 mm in diameter and 2 mm apart, were cut into
agarose plates by using a stainless steel template. The
concentration of granulocytes was adjusted in RPMI 1640
containing 10% heat-inactivated fetal calf serum so that 106
leukocytes were added to the middle well of the plate.
Chemotactic factors were generated from fresh autologous
serum by incubation with zymosan and pipetted into one
peripheral well. The other peripheral well contained tissue
culture medium alone. After incubation of the plates for 4 h
at 37°C in an atmosphere of 5% C02, the cells were fixed
with methanol and formaldehyde, the agar was removed
from the plate, and the plate was air dried. The agarose was
discarded, and the granulocytes were stained with Wright
solution. Cells were quantitated by using a 1-by-i-mm mi-
croscope eyepiece grid. This was positioned between the
center and peripheral wells and moved in a vertical direction
until all cells within the grid were counted. Cell migration
was measured by counting all cells between the middle well,
which contained the granulocytes, and the well containing
the chemotactic factors or the control well, which contained
tissue culture medium. Results were expressed in terms of
the total number of PMNs counted.
Chemotaxis data were examined by measuring both abso-
lute cell counts and linear migrating distance. Both methods
yielded similar results; however, because absolute counts
more clearly reflected activity in this assay, these data were
chosen for presentation.
All assays were done daily in triplicate for 12 days.
Experimental day-to-day variation was similar to that previ-
ously reported (4).
Bacterial pathogens. The following laboratory strains of
bacteria were used in the assays of chemiluminescence,
phagocytosis, and killing described below: Streptococcus
pneumoniae type 12F, Escherichia coli, Staphylococcus
aureus 502A, Haemophilus influenzae, and Pseudomonas
aeruginosa. Organisms were inoculated into several tubes of
Todd-Hewitt broth and incubated at 37°C overnight. The
suspensions were centrifuged at 1,000 x g for 10 min at 25°C
and then washed and suspended in Geys balanced salt
solution (pH 7.2) to a concentration of 5 x 108 to 109/ml. The
bacterial suspension was divided into samples and stored at
-70°C until they were used.
Chemiluminescence. The interaction of granulocytes with
pooled human sera and two bacterial pathogens, i.e., S.
aureus and S. pneumoniae, or with zymosan particles was
tested by chemiluminescence methods described in detail
previously (17). On the day of each assay, bacteria were
opsonized with 40% test serum (0.5 ml) for 30 min at 37°C.
After incubation, 0.5 ml of Geys balanced salt solution was
added to each opsonized bacterial suspension. This 1-ml
volume was added to the reaction vial for a final bacte-
rium/PMN ratio of 100:1.
Chemiluminescence was measured at room temperature in
dark-adapted polypropylene scintillation vials, with the
photomultiplier tube of a Beckman LS 9000 liquid scintilla-
tion spectrophotometer set in the out-of-coincidence mode.
The vials contained 5 x 106 PMNs in 4 ml of Geys balanced
salt solution and were equilibrated in the scintillation
counter until a stable background was reached. Chemilum-
inescence was initiated by adding 1 ml of previously opson-
ized bacteria (5 x 108 to 109) to each vial. All vials were
counted for 15 s at approximately 7-min intervals for 90 min.
Chemiluminescence was expressed as peak activity through-
out these studies, and maximum or peak counts per minute
usually occurred between 15 and 45 min. Absorbed and
hypogammaglobulinemic sera were used to measure nonspe-
cific opsonization (i.e., complement and nonantibody serum
proteins), and these background counts were subtracted
from the total counts per minute of the experimental sam-
ples.
Phagocytosis and bacterial killing. The killing of bacteria
was measured first by using the colony count bactericidal
method (15). Briefly, each 1-ml incubation mixture included
5 x 106 CFU of bacteria and 10% autologous serum. The 2-h
incubation was done at 37°C in plastic test tubes with
horizontal rotation on a shaker at a rate of 120 rpm.
Immediately after incubation, neutrophils were lysed by
adding 9 ml of sterile distilled water to the reaction mixtures,
serial dilutions of the bacteria were made in 0.9% NaCl, and
100 ,u of the dilutions was spread on Trypticase soy agar
(BBL Microbiology Systems) plates to quantitate viable
bacteria.
After preliminary studies with the colony count assay, a
fluorochrome microassay with acridine orange as an indica-
tor of viable cellular material (14) was used to directly
evaluate phagocytic and microbicidal functions of granulo-
cytes. Blood was drawn in a syringe with no anticoagulant,
and a leukocyte monolayer was prepared by placing 0.2-ml
samples of blood on sterile circular cover slips. All cover
slips were incubated at 37°C in a humidified 5% CO2 incu-
bator for 60 min. After incubation, the clot and serum were
gently washed from the cover slip, and the cover slip was
gently rinsed with Hanks balanced salt solution to remove
nonadherent cells. A 0.2-ml amount of the bacterial suspen-
sion was added to the monolayer, and the cover slip was
incubated at 37°C for 90 min. Each cover slip was then
carefully rinsed and stained with 0.14% acridine orange for
45 s. The cover slips were mounted on glass slides with the
monolayer side down, and the edges were sealed with clear
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TABLE 2. Bacterial phagocytosis and killing by circulating and marginated granulocytesa
Phagocytosisb % Killing
Bacterium
Pre Post PC Pre Post PC
E. coli 3.29 ± 0.82 4.21 t 1.11 NS 44 t 9 63 t 4 <0.02
S. aureus 5.57 t 2.42 6.56 t 1.89 NS 66 t 12 81 t 13 NS
S. pneumoniae 5.58 t 1.55 7.82 t 1.14 NS 60 t 9 85 t 6 <0.01
P. aeruginosa 7.30 ± 0.85 9.33 t 1.87 NS 69 t 3 85 ± 4 <0.01
H. influenzae 8.62 ± 1.27 13.24 ± 3.03 <0.02 69 ± 2 80 ± 4 <0.05
a Values are expressed as the mean of five samples ± the standard error of the mean. Pre and Post are as defined in Table 1, footnote b.
b Expressed as a phagocytic index, i.e., the average number of bacteria ingested per granulocyte in 100 cells counted.
c NS, Not significant.
nail polish. The cells were examined with an immersion
objective. To quantitate phagocytic capacity, the total num-
bers of dead (red) and live (green) intracellular bacteria in
100 leukocytes were counted on each of the three cover
slips. Killing and phagocytic capacity were determined by
the following formulas: % killing = [(number of red orga-
nisms)/(number of red and green organisms per 100 leuko-
cytes)] x 100; phagocytic capacity = (number of red and
green organisms)/(100 leukocytes).
Statistics, Statistical analyses were done with the Student
t test.
RESULTS
Marginated leIfocytes. Peripheral blood obtained 18 min
after subcutaneous epinephrine treatment contained abso-
lute neutrophil counts averaging 7,197 + 2,047/mm3 as
compared to 3,332 ± 958/mm3 before epinephrine treatment.
This finding represented an increase of 116%, with a range of
72 to 225%. Although blood samples taken after epinephrine
treatment contained both circulating and marginated leuko-
cytes, these samples are referred to as marginated cells for
clarity in presentation. It was assumed that any observed
differences in functional capacity were attributable to the
marginated pool.
Results for experiments which examined adherence, ran-
dom migration, and chemotaxis of granulocytes are summa-
rized in Table 1. No significant differences between circulat-
ing and marginated granulocytes were observed in these
assays.
Although peak chemiluminescence activity was similar for
the two populations of granulocytes, the response kinetics
differed in that the peak responses were achieved more
rapidly with the marginated pool (data not shown). This
result was evident for both bacterial strains, i.e., S. aureus
and S. pneumoniae, as well as for opsonized zymosan
particles.
Phagocytosis, as measured by a phagocytic index (in-
gested bacteria per granulocyte), was greater for marginated
neutrophils than for circulating cells, but this finding reached
statistical significance only for phagocytosis of H. influenzae
(Table 2). Data for bactericidal capacity, as measured by
both the acridine orange fluorochrome microassay and the
colony count method, were similar; those for the microassay
are presented in Table 2. Killing capacity was greater for
marginated granulocytes, with increased function statisti-
cally significant for four of the five bacterial strains tested.
Bone marrow reserve granulocytes. Ten experiments in
which the number of granulocytes was almost tripled after
intravenous hydrocortisone administration were analyzed
(Table 3). The adherence of bone marrow reserve granulo-
cytes was increased by an average of 8% above that of
control neutrophils, but this difference was not statistically
significant. Random migration was unchanged in bone mar-
row granulocytes, as was interaction with serum opsonins.
Chemotaxis averaged 21% above that of circulating cells (P
< 0.05), while peak chemiluminescence responses to
zymosan, S. pneumoniae, and S. aureus were similar for the
two populations of granulocytes.
Bone marrow reserve granulocytes showed significantly
higher phagocytic and killing responses than circulating cells
did with both assays, and data for the fluorochrome microas-
say are summarized in Table 4. These differences were
consistent for all five bacterial strains studied.
DISCUSSION
The leukocytosis which accompanies systemic bacterial
infection is generally interpreted as a host response which
augments the immune defense. Early in the course of the
disease, the additional circulating neutrophils come primar-
ily from the marginated pool, whereas bone marrow reserves
account for the majority of cells during continued infection
or during convalescence (6). The granulocytes in bone
marrow reserves represent a younger population of cells
with functional capacities different from those of peripheral
circulating PMNs; the more consistently observed differ-
ences have included decreased adherence (7, 9), increased
chemiluminescence, and increased release of myeloperox-
idase (7).
There is disagreement as to whether the marginated neu-
trophils constitute a population which possesses properties
TABLE 3. Characteristics of circulating and bone marrow reserve granulocytesa
No. of Random Peak chemiluminescence response (cpm) with:Granulocyte granulocyteS/MM3 Adherence migration. ChemotaxisZZymosan S. pneumoniae S. aureus
Pre 2,464 ± 535 59 ± 4 473 ± 216 1,466 ± 293 317,964 ± 63,238 48,350 ± 9,211 85,439 ± 6,509
Post 7,317 ± 1,648 63 ± 6 531 ± 189 2,071 ± 214 364,052 ± 81,735 46,873 ± 7,752 89,031 ± 8,625
a Values are expressed as the mean of 10 samples ± the standard error of the mean. Pre, Circulating granulocytes isolated before hydrocortisone treatment;
Post, bone marrow reserve granulocytes isolated after hydrocortisone treatment. P values (Pre and Post) were as follows: number of granulocytes per cubic
millimeter, <0.001; chemotaxis, <0.05. All other P values were not significant.
b Number of migrated cells in a single plane.
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TABLE 4. Bacterial phagocytosis and killing by circulating and bone marrow reserve granulocytesa
Phagocytosisb % Killing
Bacterium
Pre Post P Pre Post P
E. coli 3.3 ± 0.8 4.6 ± 0.5 <0.05 44 ± 9 61 ± 5 <0.05
S. aureus 5.6 ± 1.4 7.3 ± 0.6 <0.05 66 ± 12 76 ± 4 <0.05
S. pneumoniae 5.6 ± 1.6 8.4 ± 1.0 <0.05 60 ± 9 75 ± 6 <0.05
P. aeruginosa 7.3 ± 0.8 9.1 ± 0.9 <0.05 69 ± 3 85 ± 3 <0.02
H. influenzae 8.6 ± 1.3 11.2 ± 1.2 <0.05 69 + 2 75 ± 4 <0.05
a Values are expressed as the mean of 10 samples ± the standard error of the mean. Pre and Post are as defined in Table 3, footnote a.
b Expressed as a phagocytic index, i.e., the average number of bacteria ingested per granulocyte in 100 cells counted.
different from circulating PMNs and thereby enhance elim-
ination of foreign antigens such as bacterial pathogens. One
report concluded that marginated cells were a younger
population, as suggested by differences in alkaline phospha-
tase content (5). However, other studies which also assayed
alkaline phosphatase to determine neutrophil maturity dis-
agreed (12, 13). There appears to be a rapid equilibration of
diisopropyl fluorophosphate-labeled granulocytes between
the marginated and circulating vascular compartments (2).
These data make it less likely that marginated PMNs migrate
from the endothelium to the circulation or into tissue as a
consequence of maturation per se. Location in these com-
partments appears to be more likely a random event. If
location is random, then the functional capacities of cells
from the circulating or marginated pools should be identical.
In the present study, we harvested neutrophils after epi-
nephrine administration at 18 min postinjection. This early
sampling should eliminate potential contamination with bone
marrow reserve cells, which are released much later (2).
Moreover, there was a small but insignificant change in the
appearance of immature neutrophils at 18 min post-
epinephrine treatment, a characteristic of marginated cells.
On the other hand, after infusion of hydrocortisone, 40 to
50% of the granulocytes were in immature forms, a finding
which supports the idea that these cells originate as bone
marrow reserve cells. These data, similar to data in previous
reports, allow the interpretation that differences in func-
tional capacities for the various populations of granulocytes
exist.
Earlier studies have compared granule protein content
along with some functional characteristics of marginated and
circulating granulocytes; differences were generally not sta-
tistically significant (7). Marginated PMN adherence was
shown to be decreased in one study (9) but unchanged in
another (7). Methodologic variables may have accounted for
these differences since epinephrine was given intramuscu-
larly in the first study but subcutaneously in the latter.
Hetherington and Quie (7) also examined peak chemilumi-
nescent responses after stimulation with opsonized zymosan
and phorbol myristate acetate, chemotaxis induced by
zymosan-activated serum and E. coli factor, and PMN
content of myeloperoxidase, lactoferrin, and 0-glucuron-
idase. They concluded that granulocytes of these two pools
were functionally equivalent and that granule protein con-
tents were identical. The major difference between this
earlier study and our study was that subjects were given only
0.3 ml of epinephrine (1:1,000), whereas we administered 0.4
ml/m2 of body surface area. With this higher dose, margin-
ated granulocytes accounted for 54% of the recovered cells,
versus 26% (7) with the lower dose. The dilution effect of
normal circulating granulocytes in assays designed to eval-
uate differences between blood samples taken before and
after epinephrine treatment might prevent delineation of
functional changes, particularly when marginated cells rep-
resent a small minority of the total population.
The earlier events of neutrophil function, i.e., adherence,
migration, chemotaxis, and chemiluminescence, appear to
be unaltered in marginated granulocytes, although chemo-
taxis is enhanced in the bone marrow reserve population.
These findings confirm previous observations with some-
what different methods. However, in marginated granulo-
cytes the later events, i.e., phagocytosis and killing, were
enhanced over those in circulating PMNs, particularly so in
bone marrow reserve granulocytes. These differences for
phagocytosis in the marginated pool were significant (P <
0.02) with H. influenzae but were not significant, although
they were higher, with E. coli, S. aureus, S. pneumoniae,
and P. aeruginosa. More discriminatory were assays of
bacterial killing in which capacity was significantly enhanced
(P < 0.05) against E. coli, S. pneumoniae, P. aeruginosa,
and H. influenzae. Killing of S. aureus did not reach statis-
tical significance. Bone marrow reserve cells appear to be
even more active, with enhanced phagocytic and killing
capacity observed for all of the bacterial pathogens studied.
Most important from these data is the consistent observa-
tion of increased phagocytosis and killing function for mar-
ginated and bone marrow reserve granulocytes. This sug-
gests an enhancement of host defense provided by recruit-
ment of phagocytic cells. Increased activity is probably not
the result of interaction with epinephrine or hydrocortisone
since in vitro incubation of PMNs with these pharmaceuti-
cals did not alter function (data not shown). More likely is an
innate difference in function based on maturation or in vivo
preservation of activity during margination.
The earlier respiratory burst seen in most chemilumines-
cent experiments may account for some augmentation in
killing efficiency. Other possible mechanisms include in-
creases in granule enzyme content, hydroxyl-radical produc-
tion, or interaction with opsonins. To date, no studies have
delineated such differences between the various pools of
PMNs. It is certainly possible that the many factors which
eventually result in bacterial killing are all relatively more
efficient in reserve cells. Slight differences for each step are
of course difficult to demonstrate in vitro.
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